Tuesday, January 11, 2022

< + > Medicare Seeks To Limit Coverage For Controversial Alzheimer’s Drug Aduhelm

Doctors demanded the FDA revoke its approval for the Alzheimer’s drug Aduhelm, which can cause side effects like brain bleeding.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > AI and Automation in Healthcare – 2026 Health IT Predictions

As we wrap up another year and get ready for 2026 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Pred...